Artificial Intelligence in Drug Development: Opportunities, Challenges, and Considerations for Successful Adoption
Abstract: Artificial intelligence (AI) has the potential to transform the drug development process, enabling faster, more efficient, and more targeted drug discovery and development. AI used in combination with human expertise, particularly in the areas of pharmacology, toxicology, and clinical trials.
Keywords: Artificial Intelligence, Drug Development, Data Quality, Clinical Trials
How to Cite?: Yash Garg, "Artificial Intelligence in Drug Development: Opportunities, Challenges, and Considerations for Successful Adoption", Volume 12 Issue 3, March 2023, International Journal of Science and Research (IJSR), Pages: 948-948, https://www.ijsr.net/getabstract.php?paperid=SR23317144600, DOI: https://dx.doi.org/10.21275/SR23317144600